B
Biofrontera Inc. (BFRI)
NCM – Real Time Price. Currency in USD
0.97
+0.02 (2.58%)
At close: Jun 26, 2026, 4:00 PM EDT
0.97
-0.00 (-0.21%)
After-hours: Jun 26, 2026, 7:18 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.97
+0.02 (2.58%)
At close: Jun 26, 2026, 4:00 PM EDT
0.97
-0.00 (-0.21%)
After-hours: Jun 26, 2026, 7:18 PM EDT
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
| Name | Position |
|---|---|
| Dr. Hermann Luebbert Ph.D. | CEO, President & Chairman |
| Mr. Daniel Hakansson J.D. | Senior Corporate Counsel |
| Mr. Eugene Frederick Leffler III | Chief Financial Officer |
| Mr. George P. Jones | Chief Commercial Officer |
| Mr. Jon Lyons M.B.A., Ph.D. | Vice President of Scientific & Medical Affairs |
| Ms. Erica F. Gates CPA, M.B.A. | VP of Finance & Principal Accounting Officer |
| Ms. Samantha Widdicombe | Senior Vice President of Sales & Strategic Accounts |
| Date | Type | Document |
|---|---|---|
| 2026-06-17 | 8-K | form8-k.htm |
| 2026-05-14 | 8-K | form8-k.htm |
| 2026-05-14 | 10-Q | form10-q.htm |
| 2026-04-30 | DEF 14A | formdef14a.htm |
| 2026-03-19 | 8-K | form8-k.htm |
| 2026-03-19 | 10-K | form10-k.htm |
| 2026-03-09 | 8-K | form8-k.htm |
| 2026-02-26 | 8-K | form8-k.htm |
| 2026-02-09 | 8-K | form8-k.htm |
| 2026-01-13 | 8-K | form8-k.htm |